tiotropium-bromide has been researched along with Weight-Loss* in 2 studies
1 review(s) available for tiotropium-bromide and Weight-Loss
Article | Year |
---|---|
[Clinical profile of roflumilast].
Patients with chronic obstructive pulmonary disease (COPD) and associated bronchitis are at higher risk of exacerbations, which are a major cause of morbidity and impaired quality of life. Moreover, exacerbations are associated with more rapid disease progression and higher mortality. The typical symptoms of chronic bronchitis (chronic cough and sputum production) are correlated with inflammatory markers in COPD. Roflumilast is an anti-inflammatory drug belonging to the novel therapeutic class of phosphodiesterase-4 inhibitors and is the first drug to be developed for the treatment of a specific COPD phenotype (COPD associated with chronic bronchitis). The results of clinical trials indicate that, in patients with COPD associated with chronic bronchitis and a history of exacerbations, roflumilast improves pulmonary function and reduces the symptoms and frequency of exacerbations requiring medical intervention. This effect is maintained when regular treatment with a long-acting bronchodilator or an inhaled corticosteroid is added. Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Forced Expiratory Volume; Humans; Mice; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Rats; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Weight Loss | 2010 |
1 other study(ies) available for tiotropium-bromide and Weight-Loss
Article | Year |
---|---|
[No medication for COPD patients who do not stop smoking? "Fat diabetics are treated, too"].
Topics: Adult; Bronchodilator Agents; Diabetes Mellitus; Forced Expiratory Volume; Humans; Middle Aged; Pulmonary Disease, Chronic Obstructive; Scopolamine Derivatives; Smoking; Smoking Cessation; Spirometry; Tiotropium Bromide; Weight Loss | 2003 |